Insider sale
KYMERA THERAPEUTICS, INC.
$21.02M
233.23K shares
ATLAS VENTURE FUND X, L.P. plans to sell 233.23K shares of KYMERA THERAPEUTICS, INC. valued at approximately $21.02M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Private Placement
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/11/2020 | Private Placement Cash | 100.93K | — |
| Total | 100.93K | ||
Completed
Units to sell
92.17K
Market value
$8.33M
Units to sell
12.90K
Market value
$1.17M
Units to sell
11.74K
Market value
$1.06M
Units to sell
88.00
Market value
$7.9K
Units to sell
12.00
Market value
$1.1K
Units to sell
5.90K
Market value
$530.7K
Units to sell
385.00
Market value
$34.7K
Units to sell
2.75K
Market value
$247.8K
Units to sell
2.20K
Market value
$197.9K
Units to sell
4.16K
Market value
$374.2K
Planned — Approximate Date
Units to sell
100.93K
Market value
$9.07M
Units
233.23K
Value
$21.02M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/18/2026 | 92.17K | $8.33M | — | Completed |
6/18/2026 | 12.90K | $1.17M | — | Completed |
6/18/2026 | 11.74K | $1.06M | — | Completed |
4/22/2026 | 88.00 | $7.9K | — | Completed |
4/22/2026 | 12.00 | $1.1K | — | Completed |
4/22/2026 | 5.90K | $530.7K | — | Completed |
4/15/2026 | 385.00 | $34.7K | — | Completed |
4/15/2026 | 2.75K | $247.8K | — | Completed |
4/15/2026 | 2.20K | $197.9K | — | Completed |
4/14/2026 | 4.16K | $374.2K | — | Completed |
| Planned — Approximate Date | ||||
6/18/2026 | 100.93K | $9.07M | Nasdaq | Planned |
| Total | 233.23K | $21.02M | ||